methotrexate has been researched along with Abnormalities, Congenital in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaidos, JKJ; Kane, SV | 1 |
| Friedman, S; Kammerlander, H; Larsen, MD; Magnussen, B; Nørgård, BM; Winter, RW | 1 |
| Hashkes, PJ | 1 |
| Hoeltzenbein, M; Meister, R; Schaefer, C; Wacker, E; Weber-Schoendorfer, C | 1 |
| Beghin, D; Bernard, N; Chambers, C; Clementi, M; Cuppers-Maarschalkerweerd, B; Elefant, E; Eleftheriou, G; Johnson, D; Kao, K; Koren, G; Malm, H; Meister, R; Ornoy, A; Pistelli, A; Pupco, A; Schaefer, C; Shechtman, S; Vial, T; Wacker, E; Weber-Schoendorfer, C; Winterfeld, U | 1 |
| Callahan, ST; Cheetham, TC; Chen, N; Cooper, WO; Griffin, MR; Li, DK; Morgan, TM; Ray, WA; Shintani, AK; Stein, CM | 1 |
| Arena, JF; Dawson, AL; Reefhuis, J; Riehle-Colarusso, T | 2 |
| Damkier, P; Kaplan, YC | 1 |
| Gutierrez, JC; Hwang, K | 1 |
| Andersen, JT; Askaa, B; Eck, LK; Jensen, TB; Jimenez-Solem, E; Mastrogiannis, D; Nielsen, TK; Poulsen, HE; Torp-Pedersen, A | 1 |
| Halperin, R; Pansky, M; Rozovski, U; Schneider, D; Svirsky, R; Vaknin, Z | 1 |
| RODRIGUEZDEAGNESE, LR; YANZON, NA | 1 |
| Morgan, FC; Whitecar, PW; Yedlinsky, NT | 1 |
| Villiger, PM; von Esebeck, M; Østensen, M | 1 |
| Abu-Musa, AA; Nassar, AH; Usta, IM; Yunis, KA | 1 |
| Goldstein, DP; Pastorfide, GB | 1 |
4 review(s) available for methotrexate and Abnormalities, Congenital
| Article | Year |
|---|---|
Sexuality, Fertility, and Pregnancy in Crohn's Disease.
Topics: Congenital Abnormalities; Crohn Disease; Female; Fertility; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Infant, Small for Gestational Age; Infertility, Female; Infertility, Male; Male; Methotrexate; Pregnancy; Pregnancy Complications; Premature Birth; Risk Factors; Sexual Health; Stillbirth; Tumor Necrosis Factor-alpha | 2017 |
50 Years Ago in The Journal of Pediatrics: Methotrexate-Induced Congenital Malformations: With a Review of the Literature.
Topics: Antirheumatic Agents; Congenital Abnormalities; History, 20th Century; Humans; Methotrexate; Pediatrics | 2018 |
The toxicity of methotrexate in male fertility and paternal teratogenicity.
Topics: Animals; Antirheumatic Agents; Congenital Abnormalities; Fathers; Female; Humans; Infertility, Male; Male; Methotrexate; Patient Education as Topic; Pregnancy; Pregnancy Outcome; Semen Preservation; Spermatogenesis; Time Factors | 2017 |
Methotrexate embryopathy after therapy for misdiagnosed ectopic pregnancy.
Topics: Abnormalities, Drug-Induced; Abortifacient Agents, Nonsteroidal; Adult; Congenital Abnormalities; Diagnostic Errors; Female; Fetal Diseases; Humans; Infant, Newborn; Methotrexate; Ovulation Induction; Pregnancy; Pregnancy, Ectopic | 2007 |
14 other study(ies) available for methotrexate and Abnormalities, Congenital
| Article | Year |
|---|---|
Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study.
Topics: Adult; Cohort Studies; Congenital Abnormalities; Denmark; Fathers; Female; Humans; Immunosuppressive Agents; Infant, Small for Gestational Age; Male; Methotrexate; Odds Ratio; Premature Birth; Young Adult | 2017 |
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Case-Control Studies; Cohort Studies; Congenital Abnormalities; Fathers; Female; Humans; Male; Methotrexate; Pregnancy; Pregnancy Outcome; Prospective Studies | 2014 |
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Case-Control Studies; Cohort Studies; Congenital Abnormalities; Dose-Response Relationship, Drug; Female; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies; Rheumatic Diseases; Risk Factors | 2014 |
Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.
Topics: Adult; Arthritis; Cohort Studies; Congenital Abnormalities; Female; Fetal Death; Follow-Up Studies; Humans; Hydroxychloroquine; Immune System Diseases; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha | 2014 |
Maternal exposure to methotrexate and birth defects: a population-based study.
Topics: Congenital Abnormalities; Female; Humans; Maternal Exposure; Methotrexate; Pregnancy; Prenatal Exposure Delayed Effects | 2014 |
In utero exposure to methotrexate and risk of congenital malformations.
Topics: Congenital Abnormalities; Female; Humans; Maternal Exposure; Methotrexate; Pregnancy; Prenatal Exposure Delayed Effects | 2015 |
In response to "In utero exposure to methotrexate and risk of congenital malformations".
Topics: Congenital Abnormalities; Female; Humans; Maternal Exposure; Methotrexate; Pregnancy; Prenatal Exposure Delayed Effects | 2015 |
Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy.
Topics: Adult; Cohort Studies; Congenital Abnormalities; Denmark; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Methotrexate; Paternal Exposure; Pregnancy; Premature Birth; Prescription Drugs; Registries; Risk Assessment; Statistics as Topic; Stillbirth | 2017 |
The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Congenital Abnormalities; Female; Fertilization; Humans; Israel; Methotrexate; Odds Ratio; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Safety; Time Factors | 2009 |
[COMMENTARIES ABOUT 107 CONGENITAL MALFORMATIONS].
Topics: Abnormalities, Drug-Induced; Aminopterin; Chromosome Aberrations; Chromosome Disorders; Congenital Abnormalities; Cortisone; Fetal Death; Hypoglycemic Agents; Infant, Newborn; Methotrexate; Thalidomide; Toxicology | 1963 |
Anomalies associated with failed methotrexate and misoprostol termination.
Topics: Abortion, Incomplete; Abortion, Induced; Adult; Congenital Abnormalities; Developmental Disabilities; Female; Fetus; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Methotrexate; Misoprostol; Pregnancy; Pregnancy Outcome; Risk Assessment; Ultrasonography, Prenatal | 2005 |
Therapy with immunosuppressive drugs and biological agents and use of contraception in patients with rheumatic disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Congenital Abnormalities; Contraception; Contraception Behavior; Female; Health Surveys; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Patient Compliance; Pregnancy; Pregnancy Outcome; Rheumatic Diseases | 2007 |
Pregnancy after hydatidiform mole.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Congenital Abnormalities; Contraceptives, Oral; Dactinomycin; Delivery, Obstetric; Female; Fetal Death; Humans; Hydatidiform Mole; Infant Mortality; Infant, Newborn; Infant, Premature; Intrauterine Devices; Methotrexate; Pregnancy; Recurrence; Time Factors | 1973 |
Teratologists united.
Topics: Abnormalities, Drug-Induced; Animals; Central Nervous System; Congenital Abnormalities; Genetics, Medical; Haplorhini; Humans; Methotrexate; Rats; Societies, Scientific; Thalidomide; Wales; Water Supply | 1971 |